loadpatents
name:-0.010715007781982
name:-0.0035059452056885
name:-0.0014450550079346
Osborne; Aaron Patent Filings

Osborne; Aaron

Patent Applications and Registrations

Patent applications and USPTO patent grants for Osborne; Aaron.The latest application filed is for "additive for temperature adaptive rheology profile".

Company Profile
1.3.12
  • Osborne; Aaron - Louisville KY
  • Osborne; Aaron - San Mateo CA
  • Osborne; Aaron - Plano TX
  • Osborne; Aaron - South San Francisco CA
  • Osborne; Aaron - Redding CA
  • OSBORNE; Aaron - Fort Worth TX US
  • OSBORNE; Aaron - Forth Worth TX
  • Osborne; Aaron - Tampa FL
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Additive For Temperature Adaptive Rheology Profile
App 20220289896 - Steinmetz; Alan L. ;   et al.
2022-09-15
Personalized Treatment Of Ophthalmologic Diseases
App 20220162296 - Lin; Hugh ;   et al.
2022-05-26
Variance Characterization Based on Feature Contribution
App 20220067460 - Raj; Rohan Vimal ;   et al.
2022-03-03
Treatment Of Ophthalmologic Diseases
App 20210139576 - Osborne; Aaron ;   et al.
2021-05-13
Methods Of Treating Ocular Neovascular Diseases Using Aav2 Variants Encoding Aflibercept
App 20210100856 - GASMI; Mehdi ;   et al.
2021-04-08
Combined Intramedullary and Extramedullary Surgical Aiming System And Method
App 20160374738 - Smith; Joel ;   et al.
2016-12-29
Treatment Of Polypoidal Chroidal Vasculopathy
App 20160129080 - OSBORNE; Aaron
2016-05-12
Use Of A Vegf Antagonist In Treating Ocular Vascular Proliferative Diseases
App 20150297675 - OSBORNE; Aaron
2015-10-22
Combined intramedullary and extramedullary surgical aiming system and method
Grant 9,089,375 - Smith , et al. July 28, 2
2015-07-28
Combined Intramedullary and Extramedullary Surgical Aiming System And Method
App 20150105779 - Smith; Joel ;   et al.
2015-04-16
Oct-1 as an oncoprotein and use of nucleic acid inhibitors of Oct-1 for cancer treatment
Grant 7,601,696 - Blanck , et al. October 13, 2
2009-10-13
Company Registrations
SEC0001772432Osborne Aaron

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed